Skip to main content

Table 2 Cox proportional hazard models by study prior to AIC evaluation

From: Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials

Study Variable Hazard ratio CI 95% P value
PLCO Age 1.01 (1, 1.02) 0.08
Age and PSA interaction 0.89 (0.85, 0.94) < 0.001*
BMI 1.01 (1, 1.02) 0.07
BPH 0.88 (0.81, 0.97) 0.01*
DRE 1.64 (1.46, 1.85) < 0.001*
Family history of cancer 1.43 (1.27, 1.61) < 0.001*
Finasteride use 0.69 (0.6, 0.79) < 0.001*
Log (PSA) 5.52 (5.15, 5.93) < 0.001*
African American 1.37 (1.15, 1.63) < 0.001*
African American and BMI interaction 1.05 (0.89, 1.23) 0.58
SELECT Age 1.01 (1, 1.02) 0.03*
Age and PSA interaction 0.83 (0.79, 0.88) < 0.001*
BMI 1 (0.99, 1.01) 1
BPH 0.84 (0.75, 0.93) 0.001*
Family history of cancer 1.72 (1.58, 1.88) < 0.001*
Finasteride use 0.98 (0.77, 1.25) 0.88
Log (PSA) 5.3 (4.92, 5.71) < 0.001*
African American 1.29 (1.15, 1.44) < 0.001*
African American and BMI interaction 1.15 (1.04, 1.27) 0.01*
  1. The bold and * denotes P-value < 0.05